Results 111 to 120 of about 15,690 (179)

DNA electroporation of HIV Env elicits robust T cell responses and memory B cell responses with muted serum antibody levels that can be boosted with recombinant protein. [PDF]

Vaccine
De Rosa SC, Gravett RM, Hahn WO, Villaran M, Huang Y, Schmitzberger L, Montefiori D, Domin E, Tomaras GD, Heptinstall J, Seaton KE, Ferrari G, Ozorowski G, Ward AB, Lee WH, van der Maas L, Polakowski L, Frank I, Tieu HV, Kalams SA, Garcia NMG, Huang J, Ghosh S, Purwar M, Kulp D, Humeau L, Kwong PD, McElrath MJ, Corey L, Weiner D, HVTN 304 Study Team.   +30 more
europepmc   +1 more source

ALFQ adjuvanted HIV-1 envelope protein vaccination elicits durable functional antibody and cellular responses in nonhuman primates. [PDF]

NPJ Vaccines
Shrivastava S, Carmen JM, Kim J, Peachman KK, Basu S, Alving R, Nettere D, Kundu G, Yum L, Rahman MA, Jha S, Trinh HV, Rosado L, Nguyen P, Morrison E, Swafford I, Machmach K, Bolton JS, Yates A, Misicka E, Beck Z, Mutascio S, Jobe O, Zemil McCrea M, Wieczorek L, Bergmann-Leitner ES, Polonis V, Paquin-Proulx D, Pollara J, Matyas GR, Alving CR, Thomas R, Franchini G, Ferrari G, Haynes BF, Ake JA, Rao M.   +36 more
europepmc   +1 more source

Post-Translational Modifications in HIV Infection: Novel Antiretroviral Strategies. [PDF]

Cells
Sun Y, Yang S, Ao Y, Yu W.
europepmc   +1 more source

Comparison of Immune Responses Elicited by Ad5F35-AEgp145 Alone or in Combination with rMVA-AEgp145. [PDF]

Viruses
Yang J, Ma Q, He X, Li H, Zhang X, Hao Y, Feng X.   +6 more
europepmc   +1 more source

LncRNA SNHG1 Knockdown Ameliorates HIV-1 gp120V3 Loop-Induced Microglial Neuroinflammation by Regulating the Autophagy Process. [PDF]

Inflammation
Yan X, Zuo Q, Li X, Liu Y, Wang L, Gan L, He H, Wen S, Tang H, Wang H, Pan R, Fu Y, Dong J.   +12 more
europepmc   +1 more source

Inhibition of CD4+ T-cell function by the HIV envelope protein, gp120.

Disease markers, 1990
openaire   +1 more source

Comparing CD8+ T cell ENV epitopes of two HLA class I alleles associated with different outcomes of HIV-1 infection with broadly neutralizing antibodies epitope targets discovered to date. [PDF]

Front Immunol
Ramdoyal A, Daniuk CA, Omange RW, Kimani J, Luo M.   +4 more
europepmc   +1 more source

mGem: Opening Env and harnessing NK cell effector functions to eliminate HIV-1-infected cells. [PDF]

mBio
Richard J, Finzi A.
europepmc   +1 more source

Characterization of full-length and cytoplasmic tail-truncated envelope glycoproteins incorporated into human immunodeficiency virus (HIV-1) virions and virus-like particles. [PDF]

J Virol
Anang S, Zhang S, Ennis A, Ding H, Deshpande A, Nguyen HT, Kappes JC, Sodroski JG.   +7 more
europepmc   +1 more source

Differential contributions of human oligosaccharyltransferase complexes OST-A and OST-B to HIV-1 envelope glycoprotein glycosylation. [PDF]

J Virol
Atabey T, Derking R, Newby ML, Bouhuijs JH, Snitselaar JL, Vink M, Aldon Y, Allen JD, Crispin M, Sanders RW.   +9 more
europepmc   +1 more source